Deutsche Bank AG Takes Position in Waystar Holding Corp. $WAY

Posted by Brenda Bartman on Aug 27th, 2026

Deutsche Bank AG purchased a new stake in shares of Waystar Holding Corp. (NASDAQ:WAY – Free Report) during the 2nd quarter, according to its most recent disclosure with the SEC. The fund purchased 164,614 shares of the company’s stock, valued at approximately $3,380,000.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Kennedy Capital Management LLC grew its stake in shares of Waystar by 0.5% during the fourth quarter. Kennedy Capital Management LLC now owns 106,207 shares of the company’s stock worth $3,478,000 after buying an additional 559 shares during the last quarter. Pacer Advisors Inc. grew its position in Waystar by 22.1% during the 4th quarter. Pacer Advisors Inc. now owns 3,144 shares of the company’s stock worth $103,000 after acquiring an additional 569 shares during the last quarter. State of Wyoming increased its holdings in Waystar by 45.1% in the 2nd quarter. State of Wyoming now owns 2,098 shares of the company’s stock worth $86,000 after purchasing an additional 652 shares in the last quarter. ProShare Advisors LLC raised its position in Waystar by 3.7% in the fourth quarter. ProShare Advisors LLC now owns 21,474 shares of the company’s stock valued at $703,000 after purchasing an additional 764 shares during the last quarter. Finally, Vinva Investment Management Ltd boosted its stake in shares of Waystar by 9.3% during the fourth quarter. Vinva Investment Management Ltd now owns 9,202 shares of the company’s stock valued at $301,000 after purchasing an additional 786 shares in the last quarter.

Insider Buying and Selling

In other Waystar news, CEO Matthew J. Hawkins sold 60,038 shares of the stock in a transaction dated Thursday, August 13th. The stock was sold at an average price of $25.01, for a total transaction of $1,501,550.38. Following the completion of the sale, the chief executive officer directly owned 1,835,081 shares in the company, valued at approximately $45,895,375.81. This trade represents a 3.17% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 3.50% of the company’s stock.

Waystar Stock Down 0.2%

Shares of NASDAQ WAY opened at $24.17 on Thursday. The company’s 50 day moving average price is $22.58 and its 200-day moving average price is $22.66. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.85 and a current ratio of 1.85. Waystar Holding Corp. has a 52-week low of $17.26 and a 52-week high of $41.47. The company has a market capitalization of $4.63 billion, a P/E ratio of 34.53, a price-to-earnings-growth ratio of 0.94 and a beta of 0.06.

Waystar (NASDAQ:WAY – Get Free Report) last posted its quarterly earnings data on Wednesday, July 29th. The company reported $0.43 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.03. Waystar had a net margin of 11.18% and a return on equity of 7.03%. The company had revenue of $319.67 million during the quarter, compared to analysts’ expectations of $316.21 million. During the same period in the prior year, the company posted $0.36 earnings per share. Waystar’s revenue for the quarter was up 18.1% compared to the same quarter last year. Equities analysts forecast that Waystar Holding Corp. will post 1.47 earnings per share for the current year.

Trending Headlines about Waystar

Here are the key news stories impacting Waystar this week:

Positive Sentiment: Waystar launched new AltitudeAI agentic capabilities designed to autonomously execute revenue-cycle tasks, including claims processing, denial management, documentation, and patient billing. The company says the tools connect AI-generated insights directly to action, potentially improving provider efficiency and strengthening long-term revenue growth. Waystar Launches New Agentic Solutions Transforming AI Into Action Across the Revenue Cycle
Positive Sentiment: Coverage of the product rollout highlights Waystar’s expansion of AI-powered tools across claims, denials, and revenue-cycle documentation. Successful adoption could increase customer value, support pricing power, and differentiate Waystar in healthcare payment software. Waystar expands AI-powered agentic revenue cycle tools
Positive Sentiment: Needham reaffirmed its Buy rating and set a $33 price target, implying substantial upside from the referenced stock level. The endorsement may reinforce investor confidence in Waystar’s growth and AI strategy. Needham rating report
Positive Sentiment: Waystar announced two executive leadership appointments intended to accelerate innovation, client adoption, and durable growth, adding support to management’s autonomous-revenue-cycle strategy. Waystar Expands Executive Leadership to Accelerate Innovation and Growth
Neutral Sentiment: Waystar’s analyst/investor-day transcript and presentation provide additional detail on its strategy, but the supplied reports do not identify specific new financial guidance or targets. Waystar Analyst/Investor Day Transcript
Neutral Sentiment: Reported short-interest data showed zero shares and a zero-day ratio, but the figures include an invalid percentage-change calculation and appear unreliable, offering little usable signal for investors.

Analyst Ratings Changes

WAY has been the subject of several recent research reports. JPMorgan Chase & Co. lowered their price objective on Waystar from $40.00 to $38.00 and set an “overweight” rating for the company in a research note on Thursday, April 30th. Raymond James Financial reaffirmed a “strong-buy” rating and set a $32.00 price target on shares of Waystar in a research note on Thursday, April 30th. UBS Group reduced their price objective on shares of Waystar from $37.00 to $33.00 and set a “buy” rating on the stock in a research note on Thursday, July 30th. KeyCorp reaffirmed an “overweight” rating on shares of Waystar in a research report on Friday, July 31st. Finally, Truist Financial reduced their price target on Waystar from $38.00 to $33.00 and set a “buy” rating on the stock in a research report on Thursday, August 13th. Three investment analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Waystar currently has a consensus rating of “Moderate Buy” and a consensus target price of $35.00.

Get Our Latest Research Report on WAY

Waystar Company Profile

(Free Report)

Waystar (NASDAQ:WAY) is a leading provider of cloud-based revenue cycle management and payment solutions for healthcare organizations. The company’s unified platform streamlines the entire financial continuum of patient care, from eligibility verification and claim submission to payment reconciliation and patient billing. By automating key processes and improving claim accuracy, Waystar helps providers reduce administrative overhead, accelerate cash flow and enhance overall revenue performance.

At the core of Waystar’s offering is a SaaS-based architecture that integrates seamlessly with existing electronic health record (EHR) systems and payer networks.